SaNOtize

SaNOtize, co-founded by Israeli-Canadian scientist Dr. Gilly Regev, was granted approval by Health Canada to conduct a Phase II prevention and efficacy trial for its proposed antiviral early treatment for use against COVID-19. SaNOtize has developed and patented (issued) a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microb...